Diabetes technology section
The Animas Vibe is an insulin pump with a built in Dexcom Continuous Glucose Monitor. Although there is a pump-only version of the Vibe available, the combination of the pump and monitor are what makes the Vibe stand out. The Vibe, alone, is basically the Animas 2020 pump platform from a few years ago.
The Vibe has been available in the UK since 2011. Johnson & Johnson finally submitted the Animas Vibe to the FDA in April of 2013.
A built-in bolus calculator uses personalized settings to make bolus doses more accurate and less likely to cause insulin stacking from prior boluses. The pump bolus calculator allows bolus recommendations to match the carbs you eat, bring down high readings, and minimize insulin stacking. For optimal glucose results, these bolus calculator settings are adjusted:
When choosing a pump, take the time you need to make a good choice. You will depend on this pump for 4 to 5 years, so discuss different pumps and pump options with your doctor and health care team to select the features that will be most helpful.
A pump offers convenience, more consistent insulin action from day to day, easier problem solving, easier tracking of insulin use, less hypoglycemia, less risk of hypoglycemia unawareness, and fewer morning and post-meal highs. The pump keeps a history of insulin doses and glucose readings for a handy record that helps the wearer and their physician assess control issues.
At the 72nd Scientific Sessions of the American Diabetes Association, Tandem announced that it will begin accepting orders for the t:slim™ Insulin Delivery System, the first insulin pump approved by the FDA with a touch screen, on Monday, June 11, 2012 starting at 6:00am. The product will begin shipping in August 2012.
Full press release is below.
Due to complaints about glucose meter inaccuracy, the Food and Drug Administration (FDA) is currently developing a new standard for glucose meter accuracy.
Insulet and Johnson & Johnson announced an agreement to incorporate the OneTouch technology into the Omnipod's remote controller. The next Omnipod will have a built in blood glucose meter in the PDM, allowing you to carry one less device. Insulet already has a deal with Abbott Diabetes Care to include their Freestyle technology in their new PDM but the deal isn't exclusive. Upon release, Insulet could decide to have a separate device for each blood glucose meter technology or switch to Lifescan exclusively after the Abbott deal expires in 2013.
